Oral Cancer Clinical Presentations – An Illustrative Review

Abdulhameed Alsarraf^{1, 2,} and Roqaya Alrumaih¹

¹Oral Medicine Clinic, Ministry of Health, Jahra Medical City, Kuwait

²Oral Medicine & Pathology Clinic, Kuwait Oil Company Hospital, Al-Ahmadi, Kuwait

Cite this paper

Abdulhameed Alsarraf and Roqaya Alrumaih. Oral Cancer Clinical Presentations – An Illustrative Review. International Journal of Dental Sciences and Research. 2024; 12(2):19-24. doi: 10.12691/IJDSR-12-2-1

Abstract

Oral cancer (OC) is a global health burden with a 5-year survival rate of 50%. It is traditionally defined as oral squamous cell carcinoma due to more than 90% of oral cancers histologically originating in the squamous cells. Early detection of OC improves morbidity accompanying its treatment therefore it is vital for clinicians to recognise the various clinical presentations of OC to facilitate prompt referral and early management. OC has a wide range of presentations with a spectrum ranging from a small asymptomatic lump, red or white, or mixed red and white patch to a large extensive ulcer or growth. In locally advanced cases, pain is usually present accompanied by referred pain to the ear, halitosis, trismus, dysphagia and odynophagia, intra-oral bleeding, weight loss and neck swelling. Due to the wide variation in clinical presentation, general dental practitioners and dental specialists may be unsure of suspicious lesions and the urgency of referrals required in such cases. This review aims to illustrate the clinical presentations of OC using representative clinical photographs from patients attending our Oral Medicine Clinic.

Keywords

oral cancer, oral squamous cell carcinoma, oral potentially malignant disorders, oral dysplasia, early detectione

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Petersen, P.E, “Oral cancer prevention and control- The approach of the World Health Organization,” Oral Oncology, 45(4-5),454-60, April-May 2009. [Online]. Available: https:// www.sciencedirect.com/science/article/abs/pii/S1368837508001760 [Accessed January 6, 2024].
[2]	Heller, M.A, Nyirjesy, S.C, Balsiger, R, Talbot, N, VanKoevering, K.K, Haring, C.T, Old, M.O, Kang, S.Y, Seim, N.B, “Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis.” Oral Oncology, 137, January 2023. [Online]. Available: https:// www.sciencedirect.com/science/ article/abs/pii/S1368837522005905 [Accessed January 10, 2024].
[3]	Ribeiro, M.F.A, Oliveira, M.C.M, Leite, A.C, Bruzinga, F.F.B, Mendes, P.A, Grossmann, S.D.M.C, Araujo, V.E.D, Souto, G.R, “Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review,” Oral Oncology, 130(1), June 2022. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S1368837522002251?via%3Dihub [Accessed January 8, 2024].
[4]	Liang, J, Sun, Z, “Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients,” Journal of Oral Pathology & Medicine, 50(4),371-7, September 2020.
[5]	Warnakulasuriya, S, Mak, V, Möller, H, “Oral cancer survival in young people in South East England,” Oral Oncology, 43(10),982–6, March 2007. [Online]. Available: https:// pubmed.ncbi.nlm.nih.gov/17350878/ [Accessed January 7, 2024].
[6]	Brocklehurst, P, Kujan, O, O’Malley, L, Ogden, G.R, Shepherd, S, Glenny, A-M, “Screening programmes for the early detection and prevention of oral cancer,” Cochrane Database of Systematic Reviews, (11), November 2013.
[7]	Ali, J, Sabiha, B, Jan, H.U, Haider, S.A, Khan, A.A, Ali, S.S, “Genetic etiology of oral cancer,” Oral Oncology, 70, 23-8, May 2017. [Online]. Available: https: // www.sciencedirect.com/science/article/abs/pii/S1368837517301136 [Accessed January 9, 2024].
[8]	Glenny, A-M, Furness, S, Worthington, H.V, Conway, D.I, Oliver, R, Clarkson, J.E, Macluskey, M, Pavitt, S, Chan, K.K.W, Brocklehurst, P, The CSROC Expert Panel, “Interventions for the treatment of oral cavity and oropharyngeal cancer: Radiotherapy,” Cochrane Database of Systematic Reviews, (12), December 2010.
[9]	World Health Organization (WHO), ICD-O: International classification of diseases for oncology, World Health Organization, Geneva, 2013. 3rd ed. [Online]. Available: https://iris.who.int/bitstream/handle/10665/96612/9789241548496_eng.pdf?sequence=1&isAllowed=y [Accessed January 14, 2024].
[10]	Chan, K.K, Glenny, A-M, Weldon, J.C, Furness, S, Worthington, H.V, Wakeford, H, “Interventions for the treatment of oral and oropharyngeal cancers: Targeted therapy and immunotherapy,” Cochrane Database of Systematic Reviews, (12), December 2015.
[11]	Ramadan, S, Lee, J.J, Wang, R, Jackson R.S, Pipkorn, P, Rich, J, Harbison, R.A., Zolkind, P, Kang, S.Y, Puram, S.V, Mazul, A.L, “Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancers,” Oral Oncology, 147, December 2023. [Online]. Available: https:// www.sciencedirect.com/science/article/abs/pii/S1368837523003032 [Accessed January 8, 2024].
[12]	Bagan, J, Sarrion, G, Jimenez, Y, “Oral Cancer: clinical features,” Oral Oncology, 46(6),414-7, April 2010. [Online]. Available: 10.1016/j.oraloncology.2010.03.009 [Accessed January 14, 2024].
[13]	Capilla, M.V, Olid, M.N.R, Gaya, M.V.O, Botella, C.R, Ruiz, V.B, “Factors related to survival from oral cancer in an Andalusian population sample (Spain),” Med Oral Patol Oral Cir Bucal, 12(7),518-23, November 2007. [Online]. Available: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/http:// www.medicinaoral.com/pubmed/medoralv12_i7_pE518.pdf [Accessed January 14, 2024].
[14]	Walsh, T, Macey, R, Kerr, A.R, Lingen, M.W, Ogden, G.R, Warnakulasuriya, S, “Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions,” Cochrane Database of Systematic Reviews, (7), July 2021.
[15]	Kujan, O, Huang, G, Ravindran, A, Vijayan, M, Farah, C.S, “CDK4, CDK6, Cyclin D1 and Notch1 immunocytochemical expression of oral brush liquid‐based cytology for the diagnosis of oral leukoplakia and oral cancer,” Journal of Oral Pathology & Medicine, 48(7), 566–73, June 2019. [Online]. Available: https:// pubmed.ncbi.nlm.nih.gov/31172614/ [Accessed January 9, 2024].
[16]	Alsarraf, A, Kujan, O, Farah, C.S, “Liquid-based oral brush cytology in the diagnosis of oral leukoplakia using a modified Bethesda Cytology system,” Journal of Oral Pathology & Medicine, 47(9), 887-94, June 2018.
[17]	Scully, C, Bagan, J, “Oral squamous cell carcinoma overview,” Oral Oncology, 45(4-5),301-8, April-May 2009.
[18]	Pivovar, A, Santos, Z.F.D.G.D, Torres-Pereira C.C, “Oral cancer screening for high-risk individuals in the primary healthcare setting using an active approach,” Journal of Oral Pathology and Medicine, 46(9), 786-91, February 2017.
[19]	Alsarraf, A, Alfadalah, Q, “The Clinical Practice of Oral Medicine in Specialty Dental Centres of Kuwait,” The International Arab Journal of Dentistry, 13(1), 24-9, February 2022. [Online]. Available: https://digitalcommons.aaru.edu.jo/iajd/vol13/iss1/1/ [Accessed January 14, 2024].